CONNECTIVITY
INJECTION
OCULAR
ORAL
RESPIRATORY
SKIN
MORE
COVID-19 NEWS
THE MAGAZINE
EVENTS
EXPERT VIEWS
INTERVIEWS
COMPANIES
OUR AUTHORS
ED CALENDAR
CONTRIBUTE
MEDIA PACK
ABOUT
Subscribe
CONNECTIVITY
INJECTION
OCULAR
ORAL
RESPIRATORY
SKIN
MORE
COVID-19 NEWS
THE MAGAZINE
EVENTS
EXPERT VIEWS
INTERVIEWS
COMPANIES
OUR AUTHORS
ED CALENDAR
CONTRIBUTE
MEDIA PACK
ABOUT
SEARCH
SEARCH
advanced search
WEARABLE INJECTORS
90
Issue No #90
September 10th, 2018
Download PDF
Inside the magazine
WEARABLES
Jesper Roested
Subcuject
WEARABLE INJECTORS: THE PERCEPTION OF INHERENT EXPENSE AND COMPLEXITY
There is a widespread belief that wearable injectors are too expensive and complex to really take off as a commercially viable method of drug delivery. Jesper Roested tackles the causes of this belief, and explains why it is not truly the case.
EXPERT VIEW
Paul Jansen
2014 TO 2018: AN UPDATE ON THE STATE OF WEARABLE INJECTORS
Looking back on the developments in large volume injectors since his article in ONdrugDelivery’s 2014 issue on wearable injectors, Paul Jansen reflects on the state of this technology space today, how it has progressed and the value it is likely to offer.
WEARABLES
Dr Jeannie Joughin
Enable Injections
BIOLOGIC DRUGS AND THEIR DELIVERY SYSTEMS: A SYMBIOSIS KEY TO COMMERCIAL SUCCESS
Jeannie Joughin discusses the ever-growing importance of the delivery system in the biologic combination product area, highlighting how it is the delivery system, not the drug, that defines the patient experience.
WEARABLES
Dr Paul Senn
Sensile Medical
CUSTOMISED SOLUTIONS FOR LARGE-VOLUME INJECTORS
Paul Senn discusses the products and philosophy of Sensile Medical, a developer of large volume injection devices utilising a patented micro pump technology.
WEARABLES
Ian Thompson
Ypsomed
YPSODOSE: SIMPLIFYING LARGE-VOLUME PATCH INJECTION FOR PHARMA COMPANIES AND PATIENTS
Ian Thompson provides an update on YpsoDose, a new prefilled large-volume patch injector platform, and how it is designed to simplify the approach to wearable patch injectors for both pharma companies and patients.
WEARABLES
Joe Reynolds
Noble
DEVICE TRAINING AND ONBOARDING CONSIDERATIONS FOR ON-BODY DELIVERY SYSTEMS
Joe Reynolds explains how on-body injection devices have arisen from the need to develop viscous, large-volume biopharmaceutical therapies, and how Noble’s on-body training devices can help patients learn how to use their devices correctly, reliably and safely.
WEARABLES
Graham Reynolds
West Pharmaceutical Services
THE CHANGING LANDSCAPE OF WEARABLE DRUG CONTAINMENT AND DELIVERY
Biologics and biosimilars are set to make waves in the pharmaceutical arena, but these drugs can be very difficult to deliver in a patient-centric way. Wearable injectors offer a solution to the large, infrequent dosing regimens these drugs often demand. Graham Reynolds explains more.
WEARABLES
Thomas Mayer
Sonceboz
DRUG DELIVERY MEETS AUTOMOTIVE ENGINEERING
Thomas Mayer discusses Sonceboz’s activity in the world of wearable injectors and how the company’s experiences in the automotive industry and its in-house development of high-quality motors provide significant advantages for the design and production of wearable devices.
EXPERT VIEW
Richard Featherstone
Emergo By UL
MOBILE DEVICES AND USE-RELATED RISK – TIME TO REINSTATE DETECTABILITY?
Richard Featherstone makes the case for designing detectability into the user interfaces of wearable devices, enabling the user to be an active part of ensuring the device operates safely, as intended.
Top
This website uses functional cookies (but not advertising cookies). View our
Privacy Policy
.
Close
Privacy & Cookies Policy
Close
Necessary
Always Enabled